Granite Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,910
Closed -$372K 154
2018
Q4
$372K Sell
1,910
-10,540
-85% -$2.06M 0.08% 118
2018
Q3
$2.58M Sell
12,450
-162
-1% -$31.9K 0.45% 65
2018
Q2
$2.33M Sell
12,612
-119
-0.9% -$21K 0.42% 69
2018
Q1
$2.17M Buy
12,731
+201
+2% +$36.9K 0.4% 75
2017
Q4
$2.18M Buy
+12,530
New +$2.22M 0.38% 79
2016
Q4
Sell
-1,674
Closed -$279K 119
2016
Q3
$279K Sell
1,674
-63
-4% -$10.7K 0.06% 102
2016
Q2
$264K Sell
1,737
-97
-5% -$15.1K 0.05% 105
2016
Q1
$275K Hold
1,834
0.06% 102
2015
Q4
$298K Hold
1,834
0.06% 101
2015
Q3
$254K Hold
1,834
0.05% 109
2015
Q2
$282K Hold
1,834
0.05% 107
2015
Q1
$293K Hold
1,834
0.07% 80
2014
Q4
$292K Sell
1,834
-266
-13% -$41.4K 0.07% 76
2014
Q3
$295K Hold
2,100
0.07% 78
2014
Q2
$249K Hold
2,100
0.06% 86
2014
Q1
$259K Hold
2,100
0.06% 80
2013
Q4
$240K Buy
+2,100
New +$239K 0.05% 85

Other funds holding AMGN

Granite Investment Advisors's AMGN Position: Q1 2019 in Review

Granite Investment Advisors sold out of Amgen (AMGN) in Q1 2019, closing a stake of 1,910 shares — an estimated $372K sold.

Granite Investment Advisors first reported a position in AMGN in Q4 2013 and held it in 17 quarters. The position peaked at $2.58M in Q3 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Granite Investment Advisors reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Granite Investment Advisors sold 1,910 Amgen shares in Q1 2019, an estimated $372K.
  • Granite Investment Advisors first reported a position in Amgen in Q4 2013 and held it in 17 quarters.
  • Granite Investment Advisors's Amgen position peaked at $2.58M in Q3 2018.
  • 1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Granite Investment Advisors's 13F filing for Q1 2019, filed 24 Apr 2019.